2.4.0.6 Html 7 97 1 false 0 0 false 3 false false R1.htm 0000 - Document - Document and Entity Information Sheet http://www.merrimackpharma.com/role/DocumentAndEntityInformation Document and Entity Information true false R2.htm 0010 - Statement - Condensed Consolidated Balance Sheets Sheet http://www.merrimackpharma.com/role/BalanceSheet Condensed Consolidated Balance Sheets false false R3.htm 0015 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Sheet http://www.merrimackpharma.com/role/BalanceSheetParenthetical Condensed Consolidated Balance Sheets (Parenthetical) false false R4.htm 0020 - Statement - Condensed Consolidated Statements of Operations Sheet http://www.merrimackpharma.com/role/StatementOfIncome Condensed Consolidated Statements of Operations false false R5.htm 0030 - Statement - Condensed Consolidated Statements of Cash Flows Sheet http://www.merrimackpharma.com/role/CashFlows Condensed Consolidated Statements of Cash Flows false false R6.htm 1010 - Disclosure - Nature of the Business Sheet http://www.merrimackpharma.com/role/DisclosureNatureOfTheBusiness Nature of the Business false false R7.htm 1020 - Disclosure - Summary of Significant Accounting Policies Sheet http://www.merrimackpharma.com/role/DisclosureSummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies false false R8.htm 1030 - Disclosure - Initial Public Offering Sheet http://www.merrimackpharma.com/role/DisclosureInitialPublicOffering Initial Public Offering false false R9.htm 1040 - Disclosure - Net Loss per Common Share Sheet http://www.merrimackpharma.com/role/DisclosureNetLossPerCommonShare Net Loss per Common Share false false R10.htm 1050 - Disclosure - License and Collaboration Agreements Sheet http://www.merrimackpharma.com/role/DisclosureLicenseAndCollaborationAgreements License and Collaboration Agreements false false R11.htm 1060 - Disclosure - Fair Value of Financial Instruments Sheet http://www.merrimackpharma.com/role/DisclosureFairValueOfFinancialInstruments Fair Value of Financial Instruments false false R12.htm 1070 - Disclosure - Accrued Expenses and other Sheet http://www.merrimackpharma.com/role/DisclosureAccruedExpensesAndOther Accrued Expenses and other false false R13.htm 1080 - Disclosure - Common Stock Sheet http://www.merrimackpharma.com/role/DisclosureCommonStock Common Stock false false R14.htm 1090 - Disclosure - Stock-Based Compensation Sheet http://www.merrimackpharma.com/role/DisclosureStockBasedCompensation Stock-Based Compensation false false R15.htm 1100 - Disclosure - Commitments and Contingencies Sheet http://www.merrimackpharma.com/role/DisclosureCommitmentsAndContingencies Commitments and Contingencies false false R16.htm 1110 - Disclosure - Related Party Transactions Sheet http://www.merrimackpharma.com/role/DisclosureRelatedPartyTransactions Related Party Transactions false false All Reports Book All Reports Process Flow-Through: 0010 - Statement - Condensed Consolidated Balance Sheets Process Flow-Through: Removing column 'Mar. 31, 2011' Process Flow-Through: Removing column 'Dec. 31, 2010' Process Flow-Through: 0015 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Process Flow-Through: 0020 - Statement - Condensed Consolidated Statements of Operations Process Flow-Through: 0030 - Statement - Condensed Consolidated Statements of Cash Flows mack-20120331.xml mack-20120331.xsd mack-20120331_cal.xml mack-20120331_def.xml mack-20120331_lab.xml mack-20120331_pre.xml true true